Page last updated: 2024-10-23

bisbenzimidazole and Angiogenesis, Pathologic

bisbenzimidazole has been researched along with Angiogenesis, Pathologic in 2 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Francischetti, IM1
Mather, TN1
Ribeiro, JM1
Moore, A1
Marecos, E1
Bogdanov, A1
Weissleder, R1

Other Studies

2 other studies available for bisbenzimidazole and Angiogenesis, Pathologic

ArticleYear
Tick saliva is a potent inhibitor of endothelial cell proliferation and angiogenesis.
    Thrombosis and haemostasis, 2005, Volume: 94, Issue:1

    Topics: Aedes; Animals; Anopheles; Apoptosis; Bedbugs; Bisbenzimidazole; Cattle; Cell Membrane; Cell Prolife

2005
Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.
    Radiology, 2000, Volume: 214, Issue:2

    Topics: Animals; Biomarkers, Tumor; Bisbenzimidazole; Brain Neoplasms; Cell Division; Contrast Media; Dextra

2000